Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001974640-26-000002
Filing Date
2026-03-02
Accepted
2026-03-02 07:20:55
Documents
104
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apge-20251231.htm   iXBRL 10-K 3686042
2 EX-10.7 apge-ex10_7.htm EX-10.7 88318
3 EX-10.29 apge-ex10_29.htm EX-10.29 23286
4 EX-19.1 apge-ex19_1.htm EX-19.1 124561
5 EX-23.1 apge-ex23_1.htm EX-23.1 8921
6 EX-31.1 apge-ex31_1.htm EX-31.1 16981
7 EX-31.2 apge-ex31_2.htm EX-31.2 16999
8 EX-32.1 apge-ex32_1.htm EX-32.1 14113
9 GRAPHIC img100062003_0.jpg GRAPHIC 168679
10 GRAPHIC img100062003_1.jpg GRAPHIC 83976
11 GRAPHIC img100062003_2.jpg GRAPHIC 80390
12 GRAPHIC img100062003_3.gif GRAPHIC 51962
13 GRAPHIC img100062003_4.gif GRAPHIC 29574
14 GRAPHIC img100062003_5.gif GRAPHIC 34034
15 GRAPHIC img100062003_6.gif GRAPHIC 19908
16 GRAPHIC img100062003_7.jpg GRAPHIC 99985
17 GRAPHIC img100062003_8.jpg GRAPHIC 94597
18 GRAPHIC img142381824_0.jpg GRAPHIC 8915
  Complete submission text file 0001974640-26-000002.txt   15733617

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apge-20251231.xsd EX-101.SCH 1646391
107 EXTRACTED XBRL INSTANCE DOCUMENT apge-20251231_htm.xml XML 2663318
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

EIN.: 934958665 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41740 | Film No.: 26703466
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)